跳至主要内容
临床试验/ACTRN12622000145707
ACTRN12622000145707招募中未知

Efficacy and safety of transcutaneous electrical spinal cord neuromodulation (TESCoN) after spinal cord injury

The University of Melbourne0 个研究点目标入组 80 人开始时间: 2022年1月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
15 Years 至 75 Years(—)
性别
All

入选标准

  • 1.Confirmed motor complete (AIS grade A or B), or incomplete (AIS grade C or D) tetraplegia at the time of enrolment in the study with injury below C4 vertebral level
  • 2.Subacute (2-6 months post-SCI), or chronic (12 months or more post-SCI)
  • 3.Aged between 15 and 75 years
  • 4.Have medical clearance to participate
  • 5.Able to comply with attendance requirements for the study

排除标准

  • 1.Other neurological disorders: significant head injury, brachial plexus, or peripheral nerve injury
  • 2.Previous upper limb reconstructive surgery
  • 3.Pre-existing conditions: diabetes, elevated blood pressure
  • 4.Severe cognitive impairment that precludes consent or ability to follow instructions
  • 5.Skeletal or joint injury significantly limiting range of movement of upper limbs
  • 6.Contraindications to stimulation (pacemaker, pregnancy, breast feeding, cancer).

研究者

相似试验

Driving functional recovery after spinal cord injury... | 临床试验